Axmed Signs $7M Supply Agreement Under the Resiliency through Azithromycin for Children (REACH) Programme to Supply Up to 16 Million Doses of Quality-Assured Medicines in Burkina Faso

Axmed Signs $7M Supply Agreement Under the Resiliency through Azithromycin for Children (REACH) Programme to Supply Up to 16 Million Doses of Quality-Assured Medicines in Burkina Faso

BASEL, Switzerland and NAIROBI, Kenya , March 19, 2026 /PRNewswire/ -- Axmed, the technology-enabled B2B marketplace transforming access to essential medicines across growth markets, today announced a $7 million long-term supply agreement to support the delivery of quality-assured medicines in Burkina Faso, supporting the country's participation in the Resiliency through Azithromycin for Children (REACH) programme.  Over the next three years, u…

Axmed Signs $7M Supply Agreement Under the Resiliency through Azithromycin for Children (REACH) Programme to Supply Up to 16 Million Doses of Quality-Assured Medicines in Burkina Faso - PressReach

Open the article to view the coverage from pressreach.com